Your institution may have access to this item. Find your institution then sign in to continue.
Title
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.
Authors
Cox, J D; Azarnia, N; Byhardt, R W; Shin, K H; Emami, B; Pajak, T F
Publication
Journal of Clinical Oncology, 1990, Vol 8, Issue 9, p1543